Oobli Becomes Receives FDA "No Questions" Letter for Novel Sweet Protein Produced via Precision Fermentation
USDA signals support for the safety of the Oubli Fruit Sweet Protein for use in food and beverages
Oobli, a global sweet protein platform known for its healthy sugar alternatives, announced it has received the "No questions" letter from the US Food & Drug Administration (FDA), accepting the company's conclusion that the Oubli Fruit Sweet Protein (known by its scientific name as "brazzein") is Generally Recognized as Safe (GRAS) for use as a sweetener in food and beverages.
Oobli is the first company to receive the "No questions" letter from the FDA for use of the Oubli Fruit Sweet Protein as a food ingredient. The company's brand name and sweet protein platform "Oobli'' was inspired by West African villagers who originally described the Oubli Fruit as being, "So sweet it makes children forget their mother's milk."
Oobli will sample its line of craft-brewed, low-sugar Sweet Teas, as well as its Dark and Milk Chocolates featuring the Oubli Fruit Sweet Protein, at the Future Food-Tech Conference in San Francisco from March 21-22.
Looking for a reprint of this article?
From high-res PDFs to custom plaques, order your copy today!
